Biotech firm Newron Completes Private Placement-ISIN Update
ISIN.net update: Newron Pharmaceuticals S.p.A. (Newron), a research and development company focused on novel CNS and pain therapies, announces that it has completed a private placement of 209,364 shares with a leading US-based biotechnology and healthcare specialist fund, raising gross proceeds of 5.4 million US$/CHF. The Financing will support clinical development of Sarizotan for patients…